Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY Poised To Benefit From Rexall Instability, European Expansion In 2003

This article was originally published in The Tan Sheet

Executive Summary

NBTY's reputation for strong business fundamentals and its continued success in the sluggish dietary supplement market should enable the firm to sustain share gains and capitalize on instability at major competitor Rexall Sundown as the latter faces divestiture in 2003

You may also be interested in...



Supplement Marketer/Supplier Increased Collaboration On Science Predicted

Partnerships between dietary supplement suppliers and manufacturers will accelerate in the near future to help enhance research capabilities and consumer marketing and education efforts, Integrated Marketing Group President Jeff Hilton predicted at Supply Side East in Secaucus, N.J. May 7

Supplement Marketer/Supplier Increased Collaboration On Science Predicted

Partnerships between dietary supplement suppliers and manufacturers will accelerate in the near future to help enhance research capabilities and consumer marketing and education efforts, Integrated Marketing Group President Jeff Hilton predicted at Supply Side East in Secaucus, N.J. May 7

Supplement Marketer/Supplier Increased Collaboration On Science Predicted

Partnerships between dietary supplement suppliers and manufacturers will accelerate in the near future to help enhance research capabilities and consumer marketing and education efforts, Integrated Marketing Group President Jeff Hilton predicted at Supply Side East in Secaucus, N.J. May 7

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel